Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Oligosaccharides (10-20 monosaccharide units) with high affinity for antithrombin, as well as larger high-affinity heparin fractions (having relative molecular masses between 6,000 and 21,500), all markedly accelerated the inhibition of Factor Xa by antithrombin. Moreover, all high-affinity oligosaccharides and heparins enhanced, to a similar extent, the amount of free proteolytically modified antithrombin cleaved at the reactive bond by Factor Xa. In contrast, a minimum high-affinity heparin size of approximately 18 monosaccharide units was required to significantly accelerate the inactivation of thrombin by antithrombin and to enhance the production of modified antithrombin by this enzyme. All high-affinity fractions studied had similar affinities for antithrombin, as determined by fluorescence titrations. In competition experiments, binary complexes of antithrombin with octadecasaccharide or larger high-affinity heparins, but not with smaller oligosaccharides, displaced inactivated 125I-thrombin from matrix-linked low-affinity heparin. Moreover, similar binary complexes with 3H-labeled octadecasaccharide or larger chains, but not with smaller oligosaccharides, were capable of binding to matrix-linked inactivated thrombin. These results indicate that simultaneous binding of antithrombin and thrombin to high-affinity heparin is a prerequisite to the acceleration of the antithrombin-thrombin reaction and that the minimum heparin sequence capable of binding both proteins comprises approximately 18 monosaccharide units. Similar complex formation apparently is not required for the acceleration of the antithrombin-Factor Xa reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Rosenberg, R. D., & Damus, P. S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43472-8 · Cited by 1,356
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Mechanism of the anticoagulant action of heparin
Bj�rk, I., & Lindahl, U. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421226 · Cited by 494
Self-citationFurther characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Self-citationPurification of antithrombin III by affinity chromatography
Miller-Andersson, M., Borg, H., & Andersson, L.-O. (1974) · Thrombosis Research · doi:10.1016/0049-3848(74)90001-2 · Cited by 427
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Self-citationThe Conversion of Prothrombin to Thrombin
Owen, W. G., Esmon, C. T., & Jackson, C. M. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43070-6 · Cited by 369
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L., & Lindahl, U. (1984) · Biochemical Journal · doi:10.1042/bj2180725 · Cited by 342
Self-citationExtension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Self-citationJordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70431-1 · Cited by 333
Coupling of glycosaminoglycans to agarose beads (Sepharose 4B)
Iverius, P.-H. (1971) · Biochemical Journal · doi:10.1042/bj1240677 · Cited by 316
The molecular-weight-dependence of the anti-coagulant activity of heparin
Laurent, T. C., Tengblad, A., Thunberg, L., Höök, M., & Lindahl, U. (1978) · Biochemical Journal · doi:10.1042/bj1750691 · Cited by 273
Self-citationHolmer, E., Kurachi, K., & Söderström, G. (1981) · Biochemical Journal · doi:10.1042/bj1930395 · Cited by 239
Olson, S. T., Srinivasan, K. R., Björk, I., & Shore, J. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68557-1 · Cited by 226
Self-citationGRIFFITH, M. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34385-0 · Cited by 189
Multiple functional domains of the heparin molecule.
Oosta, G. M., Gardner, W. T., Beeler, D. L., & Rosenberg, R. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.829 · Cited by 187
Olson, S. T., & Shore, J. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33366-0 · Cited by 180
Evidence for a heparin-induced conformational change on antithrombin III
Villanueva, G. B., & Danishefsky, I. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90374-6 · Cited by 137
The Binding of Low-Affinity and High-Affinity Heparin to Antithrombin. Fluorescence Studies
Nordenman, B., Danielsson, Å., & Björk, I. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12567.x · Cited by 135
Self-citationNesheim, M. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43920-2 · Cited by 131
Hoylaerts, M., Owen, W. G., & Collen, D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91066-5 · Cited by 117
N-[3H]acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans
Höök, M., Riesenfeld, J., & Lindahl, U. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90580-2 · Cited by 114
Self-citationHeparin with two binding sites for antithrombin or platelet factor 4.
Jordan, R. E., Favreau, L. V., Braswell, E. H., & ROSENBERG, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68378-x · Cited by 107
Holmer, E., Lindahl, U., Bäckström, G., Thunberg, L., Sandberg, H., Soderstrom, G. F., & Andersson, L.-O. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90208-x · Cited by 107
Self-citationOlson, S. T. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39226-8 · Cited by 103
Highly active heparin species with multiple binding sites for antithrombin
ROSENBERG, R. D., Jordan, R. E., Favreau, L. V., & Lam, L. H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90260-2 · Cited by 85
Carlström, A.-S., Liedén, K., & Björk, I. (1977) · Thrombosis Research · doi:10.1016/0049-3848(77)90107-4 · Cited by 72
Self-citationGRIFFITH, M. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5460 · Cited by 65
Binding to antithrombin of heparin fractions with different molecular weights
Danielsson, Å., & Björk, I. (1981) · Biochemical Journal · doi:10.1042/bj1930427 · Cited by 52
Self-citationEffect of heparin on thrombin inactivation by antithrombin-III
Machovich, R., & Arányi, P. (1978) · Biochemical Journal · doi:10.1042/bj1730869 · Cited by 46
Marciniak, E., & Gora-Maslak, G. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90122-0 · Cited by 7
Cited by
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., & Lose, E. J. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002053 · Cited by 1,097
Metadata
- Authors
- Danielsson, A., Raub, E., Lindahl, U., & Björk, I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1986-11
- Volume
- 261
- Issue
- 33
- Pages
- 15467-15473
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1514571277
- Cited by
- 252
- References
- 32
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.